SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019862
Filing Date
2022-05-12
Accepted
2022-05-12 16:12:29
Documents
72
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q grph-10q_20220331.htm   iXBRL 10-Q 2688129
2 EX-31.1 grph-ex311_7.htm EX-31.1 20786
3 EX-31.2 grph-ex312_9.htm EX-31.2 20794
4 EX-32.1 grph-ex321_6.htm EX-32.1 9501
5 EX-32.2 grph-ex322_8.htm EX-32.2 9510
  Complete submission text file 0001564590-22-019862.txt   8773320

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA grph-20220331.xsd EX-101.SCH 66417
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE grph-20220331_cal.xml EX-101.CAL 45723
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE grph-20220331_def.xml EX-101.DEF 231816
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE grph-20220331_lab.xml EX-101.LAB 489052
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grph-20220331_pre.xml EX-101.PRE 380880
66 EXTRACTED XBRL INSTANCE DOCUMENT grph-10q_20220331_htm.xml XML 1318840
Mailing Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY, SUITE 210 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Filer) CIK: 0001815776 (see all company filings)

IRS No.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40532 | Film No.: 22917933
SIC: 2836 Biological Products, (No Diagnostic Substances)